Search

Shaida A Andrabi

from Vestavia, AL
Age ~50
Get Report
Also known as:
Syed Shaida Andrabi, Syed A Andrabi, Syed Shalda Andrabi, Syed S Andrabi
Phone and address:
203 Castlehill Dr, Birmingham, AL 35226
Related to:
Syed AndrabiMudasir Saleem, 49
Connected to:
Mazna Andrabi, 35Charles R Andracchio, 87John L Andracchio, 37Julie S Andraca, 47Sandra Andraca, 35Sergio Andraca, 53Lisa K Andracke, 42Kim A Andracsek, 52Aurora L Andrada, 79Barbara Andrada, 78

Shaida Andrabi Phones & Addresses

  • 203 Castlehill Dr, Birmingham, AL 35226
  • Vestavia, AL
  • 3501 Saint Paul St, Baltimore, MD 21218 (410) 467-7517
  • Lutherville Timonium, MD
  • 4 Demel Ct, Owings Mills, MD 21117 (410) 356-4948

Resumes

Resumes

Shaida Andrabi Photo 1

Assistant Professor

View page
Location:
Birmingham, AL
Industry:
Research
Work:
The University of Alabama at Birmingham
Associate Professor
Uab School of Medicine
Associate Professor
Johns Hopkins School of Medicine
Assistant Professor
Education:
Otto - Von - Guericke University Magdeburg 2001 - 2004
Doctorates, Doctor of Philosophy, Philosophy, Neuroscience
Skills:
Neuroscience
Molecular Biology
Cell Biology
Cell Culture
Animal Models
Western Blotting
Immunohistochemistry
Confocal Microscopy
Biochemistry
In Vivo
Life Sciences
Elisa
Science
In Vitro
Pcr
Cell
Neuropharmacology
Peer Reviews
Shaida Andrabi Photo 2

Shaida Andrabi

View page
Shaida Andrabi Photo 3

Shaida Andrabi

View page

Publications

Us Patents

Treatment And Prevention Of Pathological Conditions Using Iduna Related Techniques And Compositions

View page
US Patent:
20120121559, May 17, 2012
Filed:
Nov 11, 2011
Appl. No.:
13/294884
Inventors:
Ted M. Dawson - Baltimore MD, US
Valina L. Dawson - Baltimore MD, US
Shaida A. Andrabi - Baltimore MD, US
Ho Chul Kang - Parkville MD, US
International Classification:
A61K 48/00
A61K 31/7105
A61P 7/02
A61P 35/00
A61P 25/28
A61P 9/10
A61K 31/7088
C12Q 1/68
US Classification:
424 9321, 514 44 A, 514 44 R, 435 61
Abstract:
Research into neuroprotective mechanisms has at its heart the goal of developing new therapeutic strategies to treat patients. For example, the compositions and induction strategies disclosed herein have use for acute injuries such as stroke or trauma, and would be extremely useful in treating patients undergoing cardiac bypass surgery, neurosurgery or other surgical cohorts where ischemia is a risk. Further, patients with subarachnoid hemorrhage, transient ischemic attacks, soldiers at risk for blast injury or patients suffering from chronic neurodegenerative diseases would also benefit from enhanced neuronal survival based upon the techniques and compositions disclosed herein. In addition, protecting against cell death by, for example, interfering with PAR polymer signaling via the compositions and processes disclosed herein, offers new therapeutic strategies for the treatment of neurologic disorders.

Detection Of Par In The Csf Of Patients With Parkinson's Disease

View page
US Patent:
20210148898, May 20, 2021
Filed:
Jun 1, 2018
Appl. No.:
16/616748
Inventors:
- Baltimore MD, US
Valina Dawson - Baltimore MD, US
Tae-In Kam - Baltimore MD, US
Liana Rosenthal - Lutherville MD, US
Shaida Andrabi - Birmingham AL, US
International Classification:
G01N 33/53
Abstract:
Poly(ADP-ribose) (PAR) is a protein implicated in numerous neurodegenerative disease states including Parkinson's disease (PD). To date, no routine laboratory test has been developed to diagnosis, assess or monitor patients suffering from PD. Disclosed herein a novel method to assess the PAR concentration in the cerebral spinal fluid (CSF) of a patient and correlate that concentration to the medical condition of a patient with PD. Also disclosed is the use of PAR as a biomarker for PD.
Control profile
Shaida A Andrabi from Vestavia, AL, age ~50 Get Report